In the News - Q1 Productions

This Week’s Top Headlines

FDA, EU Release New Pharmaceutical Regulation Agreements

Posted 3/08/17

Earlier this month, the US FDA and multiple EU drug inspection agencies released amendments to the Pharmaceutical Annex of the 1998 U.S.-EU Mutual Recognition Agreement. Under the new agreements, regulatory agencies are now able to use information gathered from mutual inspections, streamlining approval processes. Also included in the agreement are standardized approval procedures which eliminate miscommunication between agencies. This cooperation represents three years of collaboration n from both the United States and the European Union. Read the full article here.

GOP Releases Healthcare Bill to Replace Affordable Care Act

Posted 3/08/17

The Trump administration this week revealed its long-awaited healthcare bill. The law, which retains some popular aspects of its predecessor, was introduced to congress on Monday as a means of repealing and replacing the Affordable Care Act. Included in the healthcare bill are provisions for pre-existing conditions, insurance premiums, and Medicaid expansion. The new act is being referred to as the American Health Care Act, or the AHCA. Read the full article here.

Velano Vascular Releases Needle-Free Blood Draw Device

Posted 3/08/17

Velano Vascular has secured funding to begin commercializing its line of needle-free blood drawing device. The company secured FDA funding for the device in February. The device allows for medical professionals to draw blood without using a needle, as needle-induced blood drawing is one of the most common invasive medical procedures. This device will allow patients medical needs to be attended to while also maintaining non-invasive comfort levels. Read the full article here.

Merck & Co. Unveils Amazon Partnership for Diabetes Treatment

Posted 3/08/17

Merck & Co. has announced plans to incorporate technology and patient wellness into a user-friendly interface. Syncing patient information with Amazon’s voice-enabled home system, Alexa, Merck will offer diabetes patients an alternative outlet to track treatment and progress. This proposal comes a home systems rise in popularity and ability. Read the full article here.

OncoCyte Prepares for Liquid Biopsy Tests

Posted 3/08/17

OncoCyte has begun preparations to launch liquid biopsy tests this year. This announcement comes after a 300-person study has confirmed the validity of the liquid biopsy. The biopsy’s correct detection rate for lung cancer was 90% and 62% for benign nodules. The innovative diagnostic will prevent invasive biopsy procedures from being necessary, and will also be the first liquid biopsy for the use of confirming a cancer diagnosis. This was the second study executed to confirm the abilities of the biopsy, as Wistar had previously tested the biopsy. Commercial rights were handed over to OncoCyte from Wistar in January. Read the full article here.

At Veranex, we can help you with concept through to commercialization by enabling:
• Accelerated speed to market
• Controlled development costs
• Development risk mitigation
• Market viability assessment

At every stage, we navigate our clients to realize efficiencies in cost and time with our integrated and comprehensive solutions.

Visit Sponsor Website

Since TrainingPros was founded in 1997, we have been dedicated to helping our clients find the right consultant for their projects. 25 years later, we are proud to have helped hundreds of clients complete their projects and thousands of consultants find great assignments. We continue to focus on helping our clients and consultants as well as our community as a certified women-owned, award-winning staffing company that works exclusively with Learning & Development professionals to match consultants to client projects.

Visit Sponsor Website

TELCOR is the proven leader of health care software solutions for revenue cycle management (RCM) software and services designed specifically for laboratories. TELCOR RCM, our SaaS solution, and TELCOR Revenue Cycle Services, our billing service, are designed to streamline workflow, improve collections, and provide real-time analytics. Our software and service solutions are designed for the unique challenges and requirements of laboratory specialties and the clients they serve. With full access to data, labs have complete visibility of their data and can track key performance indicators. No other vendor works as hard ensuring you get paid for the work you do.

Visit Sponsor Website

At Tipping Point Media, we pride ourselves on developing innovative, creative, and technically advanced virtual training and digital marketing solutions for the life sciences industry.

We push the limits of what's possible using Augmented and Virtual Reality to create revolutionary experiences proven to increase audience engagement and retention rates.

Our dedicated team of educators, medical experts, certified programmers, and digital renaissance innovators are committed to creating high-quality custom creations that bring your company's vision to life.

Visit Sponsor Website

VantagePoint Performance trains Salespeople to be more fluent and comfortable across different situations needing different sales approaches, and we train Sales Managers to be better coaches and team leaders, with more focus and less stress.

We’re different from the average sales training company because:

We don’t believe that one approach, one system, or one methodology is absolutely superior. All have something to offer, and the “best approach” or “best system” depends on the sales situation. This is what our applied, academic research tells us.
Our use of data science, specifically Machine Learning, helps us learn about our clients more meaningfully. We provide insights from each client’s data to help them understand what drives the success of their top-performing Salespeople and Sales Managers.
We are constantly feeding what we learn back into our training products, and we invest a bigger slice of our total energy into this innovation than the average sales training company. Our clients can access always-refreshed intellectual property and content through our training subscriptions.

Visit Sponsor Website

Policy Reporter, acquired by TrialCard in 2019, provides innovative healthcare software solutions to track payer policies in near real-time and enhances market access for the therapies patients need most. The company’s patented software-driven solutions include a suite of billing and reimbursement tools for providers and laboratories, market intelligence tools for payers, and a suite of market access solutions for life science companies. Its clients include some of the world’s largest pharmaceutical and healthcare companies.

Visit Sponsor Website